Abstract
Bornaviruses are the only animal RNA viruses that establish a persistent infection in their host cell nucleus. Studies of bornaviruses have provided unique information about viral replication strategies and virus–host interactions. Although bornaviruses do not integrate into the host genome during their replication cycle, we and others have recently reported that there are DNA sequences derived from the mRNAs of ancient bornaviruses in the genomes of vertebrates, including humans, and these have been designated endogenous borna-like (EBL) elements. Therefore, bornaviruses have been interacting with their hosts as driving forces in the evolution of host genomes in a previously unexpected way. Studies of EBL elements have provided new models for virology, evolutionary biology and general cell biology. In this review, we summarize the data on EBL elements including what we have newly identified in eukaryotes genomes, and discuss the biological significance of EBL elements, with a focus on EBL nucleoprotein elements in mammalian genomes. Surprisingly, EBL elements were detected in the genomes of invertebrates, suggesting that the host range of bornaviruses may be much wider than previously thought. We also review our new data on non-retroviral integration of Borna disease virus.
Keywords: bornavirus, endogenous, integration, exaptation, integration efficiency
1. Exogenous bornaviruses
Bornaviruses are enveloped, non-segmented, negative-strand RNA viruses in the order Mononegavirales [1]. Borna disease virus (BDV) is a mammalian bornavirus and the type species of the genus Bornavirus in the family Bornaviridae. BDV was originally identified as the causative agent of Borna disease, which is characterized by non-purulent meningoencephalomyelitis of horse and sheep. Borna disease was named after the town Borna, Germany, where there was a significant epidemic of the disease at the end of the nineteenth century. The history of Borna disease traces back to the seventeenth century when Borna disease was described as ‘disease of the head’ [2].
Bornaviruses preferentially infect nervous system cells in vivo without obvious cell death. The most remarkable feature of bornavirus pathology is persistent infection in the host cell nucleus. Among the animal RNA viruses, viruses in only three taxa are known to replicate in the nucleus: the families Bornaviridae and Orthomyxoviridae and the genus Nyavirus, although the Nyavirus Midway virus has not yet been shown to replicate in the cell nucleus [1,3,4]. Because bornaviruses establish non-cytolytic persistent infections and viruses in the other two taxa cause lytic infections, bornaviruses are the only RNA viruses that have been reported to produce persistent infections in the host cell nucleus. We recently showed that BDV establishes an intranuclear persistent infection by attaching to host chromatin [5]. Thus, bornaviruses present interesting viral replication strategies and virus–host interactions.
The bornavirus genome is an 8.9 kb minus-strand RNA, which encodes six genes: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), RNA-dependent RNA polymerase (L) and accessory protein (X; figure 1). N encapisidates the viral RNA to form the viral nucleocapsid. P is a cofactor of viral polymerase L and is also a phosphorylation decoy involved in BDV pathogenicity [6–13]. Viral gene products N, P and L are the minimal components of viral ribonucleoprotein (vRNP) [14]. M and G are structural proteins. M is thought to line the inside of virions. Interestingly, M also associates with vRNP in the host cell nucleus, suggesting that M is involved in viral replication or transport of viral components [15]. G is the viral envelope glycoprotein and is involved in BDV entry, involving virion attachment to an unknown receptor and fusion of the viral envelope and cell membrane to release the vRNP into the cell cytoplasm in association with host factors [16–21]. X is a multifunctional, non-structural protein that is essential for the viral replication cycle [22], and is known to be a regulator of viral polymerase activity and an inhibitor of apoptosis in the central nervous system [23–25].
Figure 1.
Genome organization and transcripts of bornaviruses. Open reading frames (ORFs), transcription signals and representative mRNAs of the bornavirus genome are shown. S1–S3 and T1–T4 indicate transcription start and termination signals, respectively.
BDV has been reported to infect a wide range of mammalian species and several avian species [26–28]. BDV was suggested to be involved in a human psychiatric disorder in 1985 [29,30], but several more recent reports have challenged this idea [31]. Although sporadic BDV infections are still observed in several animals, the natural reservoir of BDV has not yet been identified. The bicoloured white-toothed shrew (Crocidura leucodon) is a putative natural host of BDV in central Europe [32,33]. However, in view of the range of its habitat, this does not explain the natural reservoir of BDV in other regions and suggests there must be other reservoirs [34]. Interestingly, the nucleotide sequences of BDV isolates show extremely high conservation among BDV strains, independent of host species, and region and year of isolation, except for strain no/98 [35]. Therefore, until recently, BDV was thought to be the only member of the family Bornaviridae.
However, avian bornavirus (ABV), a new member of the family Bornaviridae, was isolated from psittacine birds with proventricular dilatation disease (PDD) in 2008 [36,37]. PDD is a fatal neurological disorder characterized by lymphoplasmacytic inflammation of the central and peripheral nervous system [38]. Because Koch's postulates were experimentally fulfilled, ABV has been considered the aetiological agent of PDD [39,40]. However, cases of asymptomatic infection have been reported occasionally, indicating that ABV infection does not always cause PDD and raising the importance of epidemiological studies of ABV [41–43]. In addition to psittacine birds, ABV has been isolated from non-psittacine birds, i.e. canary (Serinus canaria), Canada goose (Branta canadensis), trumpeter swan (Cygnus buccinators) and mute swan (Cygnus olor) [44–47]. Nine ABV genotypes have been identified thus far, with seven in psittacine species, one in a canary and one in the Canada goose and swans [37,48,49]. In addition, we found ABV-like sequences in the expressed sequence tags (ESTs) database of Bengalese finch (Lonchura striata domestica) by BLAST analysis. Because these ABV-like sequences almost completely cover all ABV mRNAs, they are probably ABV transcripts. In addition, phylogenetic analysis has shown that the sequences are genetically distinct from known ABV genotypes, suggesting that they are a novel ABV genotype [50].
In addition to BDV and ABV, bornavirus N- and X/P-like sequences were detected in a cDNA library derived from the venom gland, but not the genomic DNA, of a Gaboon viper (Bitis gabonica), suggesting that there may be a reptile bornavirus (RBV) although such a virus has not yet been isolated [51]. BDV, ABV and RBV enable research involving comparison of bornavirus nucleotide and amino acid sequences, which cannot be performed with only the highly conserved BDV nucleotide sequences. Such studies provide us with interesting insights into the molecular virology and evolution of bornaviruses [52].
An increase in nucleotide sequence data has contributed to studies of novel exogenous viral nucleotide sequences and endogenous forms of viral elements. A well-known example of endogenous viral elements is the endogenous retroviruses (ERVs). During retrovirus replication, viral genomic RNA is reverse-transcribed and integrated into the host chromosome by viral reverse transcriptase (RT) and integrase. Therefore, once ERVs infect host germline cells and are integrated into the host chromosome, the integrated genomes are inherited by the host's offspring as a part of their somatic genome [53]. Nearly one-tenth of the genomes of mammals is thought to be ERV elements, for example, approximately 8% of the human genome and 10% of the mouse genome are ERV sequences [54,55]. Although viruses do not leave physical fossils, endogenous forms of viruses are regarded as molecular fossils of past retroviral infections. Thus, ERVs provide valuable information on both ancient retroviruses and coevolution of retroviruses and their hosts [53].
After ERVs were discovered in the late 1960s [56], non-retroviral RNA viruses were thought to be unable to integrate in their host genomes because they replicate without DNA intermediates. However, integration of non-retroviral RNA viruses has been reported occasionally [57–59]. In addition, since 2004, germline integration of non-retroviral RNA viruses has been reported in insects and plants [60–62]. However, no endogenous non-retroviral element was reported in the genomes of mammalian species before 2010.
2. Endogenous bornavirus-like elements
(a). Endogenous bornavirus-like elements in eukaryote genomes
During a study of the mechanism of BDV persistent infection, we unexpectedly found elements similar to BDV gene N in mammalian genomes, including the human genome, by BLAST analyses and designated them endogenous borna-like N (EBLN) elements [51]. At approximately the same time, comprehensive analyses were carried out to detect non-retroviral virus-like elements in the genomes of eukaryotes and these studies found that there were also EBLNs in the genomes of other vertebrate animals [63,64]. Moreover, we have newly identified several EBLNs in vertebrate genomes, including snake, turtle, moles, afrotherians and primates (see electronic supplementary material, table S1).
Because synteny was not observed in these species, the EBLNs were probably not derived from a single integration event. However, several EBLNs were found to be orthologous in some species, which allowed their ages to be estimated [51,63,64] (see §2b).
In addition to EBLN, endogenous bornavirus-like M-, G- and L-like (EBLM, EBLG and EBLL, respectively) elements have been reported in many vertebrate genomes [63,64]. In addition, we have newly identified EBLM and EBLL elements in the genome of many eukaryotes, including invertebrates (see electronic supplementary material, tables S2 and S3). Overall, EBL elements have been identified in the genomes of many eukaryote species: primates, rodents, chiroptera, carnivore, afrotheria, insectivora, marsupials, reptiles, fishes, insect and spider.
Thus far, no element similar to X or P has been discovered, although X/P mRNA can integrate into the chromosomes of BDV-infected cells [65] (see §3a). Although this may be a coincidence, it is possible the X/P genes of exogenous viruses may be more mutable than other genes. Indeed, the amino acid sequences of X and P genes are less conserved than other genes in a comparison between BDV and ABV. For example, in BDV and ABV, the amino acid sequences of X and P are 40.7% and 59.7% identical, respectively, whereas the sequences of N are 72.5% identical [37]. Therefore, even if integration of an X/P segment had occurred, then its nucleotide sequence would have been quite different from the nucleotide sequences of modern bornaviruses, which would prevent its detection by BLAST analysis. However, because P was identified as a BDV pathogenic factor, expression of integrated P may have adverse effects on host animals. In fact, transgenic mice expressing BDV N protein do not show any sign of neuronal disease, whereas abnormal behaviour has been observed in BDV P transgenic mice [6,7,66]. Therefore, integration and expression of a P-like protein might have an adverse effect, producing a survival disadvantage for a host animal.
Among EBL elements, N- and L-derived elements are widely distributed in eukaryote genomes compared with other EBL elements, which may be due to the conservation of their amino acid sequences among bornaviruses. In addition, there is a transcription gradient from the 3′- to 5′-end of Mononegavirales genomes, resulting in an abundance of N mRNA [67]. Most cellular processed pseudo-genes, which are thought to be generated by the same mechanism as EBL elements, are derived from genes that are highly expressed in germline cells [68]. Therefore, the transcription gradient of bornaviruses may have contributed to the abundance of EBLN elements. However, although N and L mRNA of ancient bornaviruses might have been more susceptible to reverse transcription and integration, there is presently no known explanation for such processes.
(b). Paleovirology of bornaviruses
Because viruses do not leave traditional fossils, it is difficult to estimate the minimum ages of viruses. However, endogenous viral elements give us useful information for determining minimum ages, and we and others have identified several sets of orthologous EBL elements that enabled estimates of their minimum ages [51,63,64]. In the genomes of haplorhini primates, four copies of EBLNs, designated anthropoid EBLN-1 to -4, were shown to be orthologous, suggesting that integration of anthropoid EBLNs occurred in their common ancestor. Because the divergence of Strepsirrhini and Haplorhini is estimated to have occurred about 40 million years ago (Ma), the date at which endogenous anthropoid EBLNs and EBLG were established was at least 40 Ma. Because Afrotheria EBLNs in the African elephant (Loxodonta africana), Cape hyrax (Procavia capensis) and lesser hedgehog tenrec (Echinops telfairi) and their flanking sequences are readily aligned, Afrotheria EBLNs seem to be orthologous, suggesting that they were established approximately 65 Ma [69]. Therefore, ancient bornaviruses may have coexisted with mammals and the history of bornavirus infection in mammals may go back to 65 Ma. This is the oldest endogenous non-retroviral RNA virus element identified so far. By contrast, integration of EBLN in Ictidomys tridecemlineatus (I. tridecemlineatus EBLN is designated itEBLN) is thought to have occurred recently (see §2d). Therefore, bornaviruses may have been coevolving with mammalian genomes for at least 65 Myr.
In addition, EBL elements are present in the genomes of many animals, suggesting that bornaviruses have infected such species of animals (see electronic supplementary material, tables S1–S3). Although such bornaviruses may not be easy to isolate, their nucleotide sequences may be detected in the near future. Therefore, the host range of bornaviruses may be much wider than previously thought.
(c). Establishment of endogenous bornaviruses
Bornaviruses do not encode RT and integrase genes, which leads to the question of how bornaviruses integrate into host genomes. In fact, there are several types of RT activity in cells, i.e. ERVs, retrotransposons and telomerase [70]. For example, an RNA segment of lymphocytic choriomeningitis virus (LCMV) is reverse-transcribed and integrated into its host cell chromosome by an intracisternal A-particle, an ERV element in the mouse genome [57].
Several features of EBLNs suggest a possible mechanism for integration of ancient bornavirus-derived segments [51,63,64]. EBL elements are single gene-derived segments in diverse host genome locations, implying that the endogenous elements are derived from mRNAs of bornaviruses, not from bornavirus genomic or antigenomic RNA segments. In addition, as shown in figure 2, each copy of anthropoid EBLN-1 to -4 contains a downstream 3′ poly-A tail. In addition, direct repeat (DR) sequences flank Homo sapiens EBLNs (hsEBLNs). These data suggest that integration of bornavirus segments was mediated by long interspersed nuclear elements-1 (LINE-1).
Figure 2.
Schematic of the structure of EBLN-1 to -4 in the human genome. The viral transcription signal-like sequences and 3′ poly-A tails are underlined, and the direct repeat sequences are red. (Reproduced with permission from [63].)
LINE-1 is a retrotransposon and is widely distributed in the genomes of mammals. It inserts copies of itself by a copy and paste mechanism: LINE-1 is transcribed into mRNA and then reverse-transcribed and integrated into the cell genome by two proteins encoded by LINE-1 itself. LINE-1 is also involved in retrotransposition of short interspersed nuclear elements (SINEs) and in the formation of pseudo-genes by integration of cellular mRNA [71–73]. Integration mediated by LINE-1 produces an insertion with a 3′ poly-A tail and flanked by a DR. Given the similar patterns, we suggest that integration of BDV segments was mediated by LINE-1. hsEBLN-2 may have integrated into the genome by recombination with the AluSx element, which is a SINE (figure 2). The AluSX element is immediately downstream of the hsEBLN-2 3′ poly-A tail, with a nine nucleotide DR flanking the EBLN-2/AluSX element. EBLNs in other species also have 3′ poly-A tails [51,63,64]. However, there are EBLNs with neither a poly-A tail nor a DR. The accumulation of mutations may account for some elements lacking flanking DRs and/or a 3′ poly-A tail. Some LINE-1-mediated insertions also do not have a 3′-poly-A tail or a DR [74–76]. It is interesting that the time when endogenous anthropoid EBLNs were established corresponds to the time at which LINE-1 actively retrotransposed in anthropoid genomes, supporting the LINE-1-mediated integration of anthropoid EBLNs model [77]. hsEBLN-1 to -4 also have DRs flanking the transcription start signal-like sequences and 3′ poly-A tails. Therefore, anthropoid EBLN-1 to -4 seem to be generated by independent integration of full-length N gene mRNA.
LINE-1-mediated integration of bornavirus mRNA may have contributed to the evolution of mammalian genomes. In addition, LINE-1-mediated integration may have been involved in the integration of ancient filoviruses [63]. Because LINE-1 is active in many mammalian species, RNA viruses may still be involved in the evolution of mammals by integration of viral nucleotide segments.
(d). Biological significance of endogenous borna-like nucleoproteins
Several ERV-derived genes have a function in their host which is different than the function for which they were originally selected in the virus [53]. Fv1 and Fv4 are well-known examples and act as restriction factors of murine leukemia virus in mice. Such genes are called ‘endogenous viral elements-derived immunity (EDI)’ genes, i.e. they are genes with viral ancestry that act as inhibitors of viral infection [78]. Syncytin genes are derived from the env genes of ancient retroviruses and are essential for placenta formation in several mammalian species [79–82].
To consider whether EBL elements function like ERVs, we have focused on two EBLNs that have been relatively well studied: anthropoid EBLNs and itEBLN. Although many EBLNs became pseudo-genes due to premature stop codons and frameshifts, some anthropoid EBLNs retained relatively long open reading frames (ORFs); for example, hsEBLN-1 has an ORF encoding 366 amino acids, which is comparable with the full-length BDV N protein (370 amino acids). Similarly, there is a 272 amino acid ORF in hsEBLN-2 [51,63,64]. These ORFs are also conserved among other haplorhini primate species, although some of them are disrupted by insertion of a SINE. Because anthropoid EBLN-1 to -4 may have been acquired about 40 Ma, their ORFs may have been maintained for more than 40 Myr. In addition, hsEBLN-1 to -4 nucleotide sequences have been detected in the human EST database [63]. We also found that some EBLNs were expressed as mRNAs in several human and monkey cell lines. Furthermore, hsEBLN-2 was shown to be expressed as a protein in cultured cells and to interact with several human functional proteins [83]. These data suggested that some EBLNs encode functional proteins.
If anthropoid EBLNs encode functional proteins, then natural selection should have acted on them during primate evolution. Therefore, we examined whether natural selection had operated on anthropoid EBLNs by comparing synonymous and non-synonymous substitutions [84]. No evidence of natural selection acting on EBLN-1 to -4 during evolution of anthropoid species was found using this method of analysis. This suggested that current anthropoid EBLNs may not encode proteins whose function has been conserved among current anthropoid species or that EBLN products may not have had active functions from the divergence of Strepsirrhini and Haplorhini to the divergence of current species. In addition, our finding that extant EBLN-1 contains an ORF comparable with BDV N does not necessarily support the maintenance of N function after divergence of Strepsirrhini and Haplorhini [84]. However, our analyses do not account for stop codons produced by frameshifts and may not have been sensitive enough to detect past episodic natural selection. Further analyses are needed to determine whether EBLN products have had active functions during their evolution.
Even though EBLNs may not have been expressing functional proteins during their hosts’ evolution, they may still have expressed a functionally relevant protein prior to divergence of Old and New World monkeys or were functioning as non-coding RNAs. EBLNs that have become pseudo-genes (i.e. do not contain a long ORF) might function as non-coding RNAs. Flock house virus, an RNA virus, was reported to be reverse-transcribed into DNA by an LTR-retrotransposon in Drosophila melanogaster. The resultant DNA expresses transcripts that are processed by the RNA interference (RNAi) system to inhibit viral replication [85]. Thus, EBLN transcripts may have been subject to the RNAi system, which inhibits the replication of bornaviruses.
It is also possible that proteins expressed from EBLNs acquired novel functions after divergence of the extant haplorhini primates. As described above, hsEBLN-2 was shown to interact with several functional proteins in human cells. We have confirmed the expression of hsEBLN-2 protein and identified another host factor that interacts with hsEBLN-2. Our analyses suggest that hsEBLN-2 is functional in human cells (K. Fujino & K. Tomonaga 2013, unpublished data). Although further analysis is needed to elucidate the function(s) of EBLNs, hsEBLN-2 may have acquired a novel function after the divergence of humans and chimpanzees.
Animal species that have EBLN(s) in their genomes tend to be resistant or less susceptible to modern bornavirus infection [63], suggesting a correlation between the presence of EBLNs and susceptibility to bornavirus infection. The expression of modern EBLNs may affect the replication and pathogenicity of extant bornavirus infections. Borna disease and PDD are caused by the response of immune cells to the infected cells, and BDV N protein is known to be a major antigen of CD8T cells [86,87]. Thus, it is likely that expression of EBLNs during thymic development leads to immunological tolerance to bornaviruses.
EBLNs may have encoded functional products before the divergence of Strepsirrhini and Haplorhini. For example, EBLNs may have prevented virus infection in their hosts early after the elements become endogenous, which may have provided selective advantages to the ancient primate hosts. This could have led to an increase of animals resistant to homologous or similar bornavirus infections followed by fixation of EBLNs in these species, thereby eliminating the bornavirus lineages. This loss could have resulted in the relaxation of constraints on EBLNs. Three possible mechanisms of EBLN activity as EDI have been considered. First, EBLNs may have altered the ratio of N to P gene products. It has been reported that a specific N : P ratio is required for BDV polymerase activity and that BDV N transgenic mice are resistant to BDV infection [66,88]. Therefore, expression of EBLNs may have inhibited the BDV polymerase by changing the N : P ratio. Second, EBLNs may have functioned as dominant negative proteins against the bornavirus N protein, like the ERV Gag protein that can block exogenous retroviruses in sheep at late stages of viral replication [89]. Finally, EBLNs may have been involved in immunity mediated by small RNAs as described above.
Alternatively, EBLNs may have been involved in immunological tolerance to ancient bornaviruses, conferring survival advantages to their hosts. However, this mechanism does not contribute to prevention of viral replication but to development of infection symptoms. Therefore, the host species may have become natural hosts of bornaviruses, or those bornavirus lineages may have been eliminated by other factors.
From these results, EBLNs, especially hsEBLN-2, may have had two different functions during evolution (figure 3). EBLNs may have acted as EDI genes early after becoming endogenous. The functional constrains on EBLNs may then have relaxed owing to elimination of the pathogenic viruses, leading to loss of the original EDI function. Finally, some EBLNs may have acquired novel functions. Current analyses of natural selection are not really designed to detect such patterns, which may explain why natural selection was not detected in our studies [84]. Further studies are needed to understand the biological significance of EBLNs. For example, because hsEBLNs are good models to study the function of EBLNs long after they became endogenous, it would be interesting to study the function of hsEBLN. In addition, itEBLN would be a good model for studying the function of EBLN soon after it became endogenous.
Figure 3.
Model of anthropoid EBLN(s) evolution. A schematic phylogenetic tree of primates and the possible functions of hsEBLN(s) are shown. The black arrow indicates the establishment of endogenous anthropoid EBLN(s).
itEBLN is thought to have become endogenous relatively recently [51,63,64]. However, phylogenetic analysis of EBLNs and N of exogenous bornaviruses showed that itEBLN is grouped in a cluster of exogenous bornaviruses. In addition, the amino acid sequence of itEBLN shows 77% identity with BDV N. Because there was no available genome sequence data for other squirrel species, we carried out Southern hybridization with genomic DNAs of several squirrel species [51]. These results suggested that itEBLN became endogenous after the divergence of Spermophilus and Marmota approximately 6 Ma [90,91]. We were not able to further analyse the age of itEBLN because of the lack of genomic DNA samples of closely related species of squirrels. A recent report suggested that LINE-1 in the I. tridecemlineatus genome is inactive and its retrotransposition activity may have ceased at 4–5 Ma. As described above, the 3′ poly-A tail is immediately downstream of itEBLN, suggesting involvement of LINE-1 in the generation of itEBLN [92]. It would be interesting to determine the age of itEBLN by genomic analyses of ground squirrels.
itEBLN also contains a long 203 amino acid ORF corresponding to a fragment of BDV N (residues 170–370). In addition, because the amino acid sequence identity of itEBLN and BDV N is very high, itEBLN and BDV N may have similar properties. These results suggested that itEBLN has a dominant negative effect on the BDV N protein. Further studies should investigate whether itEBLN affects BDV replication.
Considering the young age of itEBLN, this element might still be polymorphic in squirrel populations and play a role in antiviral defence against exogenous bornaviruses. Thus, it has been assumed that only squirrels having itEBLN are protected from exogenous bornavirus infection, as observed in the interaction between sheep and retroviruses [93]. Therefore, ground squirrels might be an extant model for elaborating the evolutionary relationships among exogenous RNA viruses, endogenous forms of these viruses and their hosts.
3. Integration of modern bornaviruses
(a). Integration of Borna disease virus mRNA in cultured cells
Discovery of endogenous bornavirus-like elements raised the question of whether segments of modern bornaviruses integrate into the host chromosome. We have performed a series of experiments with BDV showing that several BDV mRNAs (at least the mRNAs encoding N, X/P and N/X/P) are reverse-transcribed into cDNA in cultured BDV-infected cells [51] (figure 4a). N and X/P mRNAs have also been reported to be reverse-transcribed into cDNA in the brain of bank voles [65]. We also demonstrated that BDV N mRNA sequences are integrated into host genomic DNA in infected cultured cells and the mouse brain [51].
Figure 4.
Reverse-transcription and integration of BDV mRNA. (a) Reverse transcription of BDV mRNAs and integrated BDV mRNAs. Viral genomic structure, transcripts, PCR amplified regions and PCR results are shown. PCR results are + (positive) or – (negative). (b) Structure of BDV N and X/P DNA. The mRNAs of N and X/P are BDV genome nucleotides 44 to 1193 and 1176 to 1883, respectively. The colours of the boxes correspond to those in (c,d). (c,d) Structure of integrated (c) BDV N and (d) X/P determined by inverse-PCR. Red boxes, integrated BDV N DNAs; blue boxes, BDV X/P DNAs; black boxes, poly-A sequences; grey boxes, truncated regions; red letters, direct repeat sequences; green letters, inserted nucleotides. Pre-integration genomic structure of chromosome 7 is shown in (c). Adapted from [51].
For insights into the integration of BDV mRNA, we tried to detect integrated BDV segments by novel Alu-PCR and inverse-PCR. In addition to primers in the N gene [51], we designed new primers in the P gene for inverse-PCR to detect insertions in N/X/P and X/P mRNAs. From 40 independent subclones of infected cells, 200 inverse-PCR reactions detected eight clones of integrated BDV mRNA, including the previously reported sequences in five clones [51]. As shown in figure 4b–d, we identified sequences of integrated N and X/P mRNAs. It is interesting that seven of the eight clones of integrated BDV segments have 3′ poly-A tails, similar to mammalian EBLNs. Truncation of the 5′ sequences of BDV mRNAs was also observed in several clones. Although no consensus host sequences for integration were found, the DRs derived from host sequences are located flanking some insertions. Deletions and rearrangements were also observed in the host genome sequences adjacent to integrated BDV segments. These results are similar to the features of LINE-1-mediated integration. Therefore, reverse transcription and integration of BDV mRNAs may also be mediated by LINE-1. Although we detected only N and X/P mRNAs, all BDV mRNAs have the potential to be recognized by the LINE-1 system because of the non-specificity of LINE-1.
(b). Possible novel pathogenicity of Borna disease virus
The fact that BDV mRNA has the potential to integrate into the host genome suggested that BDV might exhibit a novel pathogenicity [94,95], i.e. BDV might act as a mutagen in infected cells. Although LINE-1 is usually silenced by a host epigenetic mechanism in somatic cells, it has been reported that LINE-1 was active in human neural progenitor cells that were permissive for BDV infection [96,97].
In addition, BDV is a candidate RNA virus vector for gene therapy of CNS cells because, unlike other potential virus vectors, BDV establishes a long-term persistent infection [98]. RNA viruses were thought to be better vectors for gene therapy than DNA viruses, because RNA viruses were believed to carry no risk of integration into their target cell genomic DNA. Therefore, detailed studies of BDV integration will help elucidate both BDV pathogenicity and help determine the risk of using a BDV vector for gene therapy.
An important question is how often BDV integration occurs in infected cells. Although the integration efficiency of BDV mRNA was thought to be very low from inverse-PCR studies, the actual integration efficiency of BDV mRNA is still unclear. To evaluate BDV mRNA integration, we tried to estimate the integration efficiency of BDV N mRNA in BDV-infected cells by Alu-real-time PCR, which consists of two PCR steps, the first PCR with primers for Alu elements and the specific gene and the second PCR with primers for the specific gene. We used the Alu primer EV-1255 [99] and BDV N-specific primer MH555 for the first Alu-PCR, and BDV N-specific primers MH549 and MH552 and a Taqman probe for the second PCR (PCR conditions, primers and probe sequences are available upon request).
To generate control human genomic DNA, which should contain a randomly integrated single copy of a BDV N mRNA sequence per cell, we constructed a retrovirus vector containing the BDV N mRNA sequence and a puromycin resistance gene. OL (human oligodendroglioma cells) and 293 cells (human embryonic kidney cells) were infected with the retrovirus vector at a multiplicity of infection (m.o.i.) of 0.1 to ensure single virus infections. Two days after infection, cells were cultured with puromycin to eliminate cells in which the retrovirus vector did not integrate into the genomic DNA, followed by isolation of genomic DNA from these cells (figure 5a). Because a retrovirus typically produces one provirus [100], the genomic DNA should contain, at most, one DNA copy of viral N mRNA per cell. To make a series of standard genomic DNAs, genomic DNA containing DNA copies of the BDV N mRNA sequence (DNA/N mRNA) was serially diluted 10-fold with genomic DNA isolated from normal OL or 293 cells. We first evaluated the sensitivity of Alu-real-time PCR for BDV N mRNA by using the serially diluted genomic DNA/N mRNA, which showed that our Alu-real-time PCR system could detect one copy of integrated N mRNA per 1000 cells (data not shown).
Figure 5.
Integration of BDV N mRNA. (a) Schematic of the establishment of cell lines containing a single copy of the BDV N mRNA sequence. (b) Infection rates of BDV-infected OL and 293 cells as a function of time post-infection. (c) Integration efficiency of 20 subclones of each BDV-infected OL and 293 cell analysed by Alu-real-time PCR. n.d.; not detected.
To evaluate the infection efficiency of BDV N mRNA in persistently infected cells, we infected OL and 293 cells with BDV strain huP2br at an m.o.i. of 0.01. After infection, genomic DNA of OL and 293 cells infected with BDV (OL/BDV and 293/BDV, respectively) were collected every week for four weeks post-infection. At four weeks post-infection, approximately 100% and 80% of OL/BDV and 293/BDV cells, respectively, were infected (figure 5b). The integration efficiency of BDV-infected OL and 293 cells was analysed by Alu-real-time PCR, but the Alu-real-time PCR values were under the detection limit, which was one copy of integrated N mRNA per 1000 cells, as described above.
We also analysed the integration efficiencies of 20 subclones of each OL/BDV and 293/BDV cell by Alu-real-time PCR (figure 5c). These cells were maintained for at least eight weeks after the percentage of infected cells reached almost 100%. Relatively high integration efficiencies were found in seven subclones of OL/BDV, with the maximum in a subclone with one BDV copy per 148 cells. The high integration efficiencies were probably due to a bottleneck effect during subcloning. However, the integration efficiencies were lower than the detection limit in all of the 293/BDV and many of the OL/BDV subclone cells. The difference between OL and 293 may be due to the kinetics of viral replication. Alternatively, the LINE-1 activity may be different between these cells, although the RT activity was under the detection limit in both cell lines [51].
These data show that the BDV integration efficiency was much lower than that of retroviruses, even in these persistently infected cell lines. In this study, we were not able to determine the precise integration efficiency of BDV N mRNA owing to the detection limit. An improvement in sensitivity is required for determination of the integration efficiency. The integration efficiencies of other mRNAs have also not been determined. From the inverse-PCR results, the integration efficiency of X/P mRNA was comparable with or less than that of N mRNA. The integration efficiency of BDV mRNA probably correlates with both the amount of mRNA and the LINE-1 activity.
LINE-1-mediated integration theoretically could happen for all RNA viruses. In addition, like LCMV, other retroelements may cause the integration of RNA viruses [57]. Although the mechanisms are still unclear, several other RNA viruses have been reported to be integrated into their host chromosomes [58–62]. Therefore, RNA viruses have the potential for integration of virus-derived segments. Thus, analysis of integration events is important for understanding the pathogenicity of RNA viruses and virus vectors [51,57,95].
4. Future
Since the discovery of EBL elements, it has been shown that non-retroviral RNA viruses and their vertebrate hosts have been associating and coevolving by integration of viral nucleotide sequences. Interestingly, these evolutionary processes may have resulted from the complex relationship among RNA viruses, retroelements and their host genomes. Thus far, there is no conclusion on whether EBL elements have had a function in their hosts. Further analyses of EBL elements will be helpful in understanding the evolutionary relationships between bornaviruses and their hosts.
Acknowledgements
We are grateful to Peter Reuther for giving useful information. M.H. was supported in part by JSPS Postdoctoral Fellowships for Research Abroad.
Funding statement
This study was supported in part by the Funding Programme for Next-Generation World-Leading Researchers (NEXT programme) from the Japan Society for the Promotion of Science (JSPS) (K.T).
References
- 1.Tomonaga K, Kobayashi T, Ikuta K. 2002. Molecular and cellular biology of Borna disease virus infection. Microbes Infect. 4, 491–500 (doi:10.1016/S1286-4579(02)01564-2) [DOI] [PubMed] [Google Scholar]
- 2.Ludwig H, Bode L. 2000. Borna disease virus: new aspects on infection, disease, diagnosis and epidemiology. Revue Sci. Tech. 19, 259–288 [DOI] [PubMed] [Google Scholar]
- 3.Cros JF, Palese P. 2003. Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res. 95, 3–12 (doi:10.1016/S0168-1702(03)00159-X) [DOI] [PubMed] [Google Scholar]
- 4.Herrel M, Hoefs N, Staeheli P, Schneider U. 2012. Tick-borne Nyamanini virus replicates in the nucleus and exhibits unusual genome and matrix protein properties. J. Virol. 86, 10 739–10 747 (doi:10.1128/jvi.00571-12) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Matsumoto Y, et al. 2012. Bornavirus closely associates and segregates with host chromosomes to ensure persistent intranuclear infection. Cell Host Microbe 11, 492–503 (doi:10.1016/j.chom.2012.04.009) [DOI] [PubMed] [Google Scholar]
- 6.Honda T, Fujino K, Okuzaki D, Ohtaki N, Matsumoto Y, Horie M, Daito T, Itoh M, Tomonaga K. 2011. Upregulation of insulin-like growth factor binding protein 3 in astrocytes of transgenic mice that express Borna disease virus phosphoprotein. J. Virol. 85, 4567–4571 (doi:10.1128/jvi.01817-10) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kamitani W, et al. 2003. Glial expression of Borna disease virus phosphoprotein induces behavioral and neurological abnormalities in transgenic mice. Proc. Natl Acad. Sci. USA 100, 8969–8974 (doi:10.1073/pnas.1531155100) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Prat CM, Schmid S, Farrugia F, Cenac N, Le Masson G, Schwemmle M, Gonzalez-Dunia D. 2009. Mutation of the protein kinase C site in Borna disease virus phosphoprotein abrogates viral interference with neuronal signaling and restores normal synaptic activity. PLoS Pathog. 5, e1000425 (doi:10.1371/journal.ppat.1000425) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Schmid S, Mayer D, Schneider U, Schwemmle M. 2007. Functional characterization of the major and minor phosphorylation sites of the P protein of Borna disease virus. J. Virol. 81, 5497–5507 (doi:10.1128/jvi.02233-06) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Watanabe Y, Ohtaki N, Hayashi Y, Ikuta K, Tomonaga K. 2009. Autogenous translational regulation of the Borna disease virus negative control factor X from polycistronic mRNA using host RNA helicases. PLoS Pathog. 5, e1000654 (doi:10.1371/journal.ppat.1000654) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Peng G, et al. 2008. Borna disease virus P protein affects neural transmission through interactions with gamma-aminobutyric acid receptor-associated protein. J. Virol. 82, 12 487–12 497 (doi:10.1128/jvi.00877-08) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Peng G, Zhang F, Zhang Q, Wu K, Zhu F, Wu J. 2007. Borna disease virus P protein inhibits nitric oxide synthase gene expression in astrocytes. Virology 366, 446–452 (doi:10.1016/j.virol.2007.04.031) [DOI] [PubMed] [Google Scholar]
- 13.Volmer R, Monnet C, Gonzalez-Dunia D. 2006. Borna disease virus blocks potentiation of presynaptic activity through inhibition of protein kinase C signaling. PLoS Pathog. 2, e19 (doi:10.1371/journal.ppat.0020019) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Schneider U. 2005. Novel insights into the regulation of the viral polymerase complex of neurotropic Borna disease virus. Virus Res. 111, 148–160 (doi:10.1016/j.virusres.2005.04.006) [DOI] [PubMed] [Google Scholar]
- 15.Chase G, Mayer D, Hildebrand A, Frank R, Hayashi Y, Tomonaga K, Schwemmle M. 2007. Borna disease virus matrix protein is an integral component of the viral ribonucleoprotein complex that does not interfere with polymerase activity. J. Virol. 81, 743–749 (doi:10.1128/jvi.01351-06) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bajramovic JJ, Munter S, Syan S, Nehrbass U, Brahic M, Gonzalez-Dunia D. 2003. Borna disease virus glycoprotein is required for viral dissemination in neurons. J. Virol. 77, 12 222–12 231 (doi:10.1128/JVI.77.22.12222-12231.2003) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Clemente R, Sisman E, Aza-Blanc P, de la Torre JC. 2010. Identification of host factors involved in Borna disease virus cell entry through a small interfering RNA functional genetic screen. J. Virol. 84, 3562–3575 (doi:10.1128/jvi.02274-09) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gonzalez-Dunia D, Cubitt B, Grasser FA, de la Torre JC. 1997. Characterization of Borna disease virus p56 protein, a surface glycoprotein involved in virus entry. J. Virol. 71, 3208–3218 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Gonzalez-Dunia D, Cubitt B, de la Torre JC. 1998. Mechanism of Borna disease virus entry into cells. J. Virol. 72, 783–788 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Honda T, Horie M, Daito T, Ikuta K, Tomonaga K. 2009. Molecular chaperone BiP interacts with Borna disease virus glycoprotein at the cell surface. J. Virol. 83, 12 622–12 625 (doi:10.1128/jvi.01201-09) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Perez M, Watanabe M, Whitt MA, de la Torre JC. 2001. N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry. J. Virol. 75, 7078–7085 (doi:10.1128/jvi.75.15.7078-7085.2001) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Poenisch M, Wille S, Ackermann A, Staeheli P, Schneider U. 2007. The X protein of Borna disease virus serves essential functions in the viral multiplication cycle. J. Virol. 81, 7297–7299 (doi:10.1128/jvi.02468-06) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Poenisch M, Staeheli P, Schneider U. 2008. Viral accessory protein X stimulates the assembly of functional Borna disease virus polymerase complexes. J. Gen. Virol. 89, 1442–1445 (doi:10.1099/vir.0.2008/000638-0) [DOI] [PubMed] [Google Scholar]
- 24.Poenisch M, Burger N, Staeheli P, Bauer G, Schneider U. 2009. Protein X of Borna disease virus inhibits apoptosis and promotes viral persistence in the central nervous systems of newborn-infected rats. J. Virol. 83, 4297–4307 (doi:10.1128/jvi.02321-08) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hayashi Y, Horie M, Daito T, Honda T, Ikuta K, Tomonaga K. 2009. Heat shock cognate protein 70 controls Borna disease virus replication via interaction with the viral non-structural protein X. Microbes Infect. 11, 394–402 (doi:10.1016/j.micinf.2009.01.006) [DOI] [PubMed] [Google Scholar]
- 26.Berg M, Johansson M, Montell H, Berg AL. 2001. Wild birds as a possible natural reservoir of Borna disease virus. Epidemiol. Infect. 127, 173–178 (doi:10.1017/S0950268801005702) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Gosztonyi G. 2008. Natural and experimental Borna disease virus infections: neuropathology and pathogenetic considerations. APMIS Suppl. 116, 53–57 (doi:10.1111/j.1600-0463.2008.000m8.x) [DOI] [PubMed] [Google Scholar]
- 28.Malkinson M, Weisman Y, Ashash E, Bode L, Ludwig H. 1993. Borna disease in ostriches. Vet. Rec. 133, 304 (doi:10.1136/vr.133.12.304-b) [DOI] [PubMed] [Google Scholar]
- 29.Bode L. 2008. Human bornavirus infection: towards a valid diagnostic system. APMIS Suppl. 21–39 [DOI] [PubMed] [Google Scholar]
- 30.Rott R, Herzog S, Fleischer B, Winokur A, Amsterdam J, Dyson W, Koprowski H. 1985. Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science 228, 755–756 (doi:10.1126/science.3922055) [DOI] [PubMed] [Google Scholar]
- 31.Hornig M, et al. 2012. Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol. Psychiatry 17, 486–493 (doi:10.1038/mp.2011.179) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hilbe M, Herrsche R, Kolodziejek J, Nowotny N, Zlinszky K, Ehrensperger F. 2006. Shrews as reservoir hosts of Borna disease virus. Emerg. Infect. Dis. 12, 675–677 (doi:10.3201/eid1204.051418) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Puorger ME, Hilbe M, Muller JP, Kolodziejek J, Nowotny N, Zlinszky K, Ehrensperger F. 2010. Distribution of Borna disease virus antigen and RNA in tissues of naturally infected bicolored white-toothed shrews, Crocidura leucodon, supporting their role as reservoir host species. Vet. Pathol. 47, 236–244 (doi:10.1177/0300985809351849) [DOI] [PubMed] [Google Scholar]
- 34.Kinnunen PM, Palva A, Vaheri A, Vapalahti O. 2013. Epidemiology and host spectrum of Borna disease virus infections. J. Gen. Virol. 94, 247–262 (doi:10.1099/vir.0.046961-0) [DOI] [PubMed] [Google Scholar]
- 35.Nowotny N, Kolodziejek J, Jehle CO, Suchy A, Staeheli P, Schwemmle M. 2000. Isolation and characterization of a new subtype of Borna disease virus. J. Virol. 74, 5655–5658 (doi:10.1128/JVI.74.12.5655-5658.2000) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Honkavuori KS, et al. 2008. Novel Borna virus in psittacine birds with proventricular dilatation disease. Emerg. Infect. Dis. 14, 1883–1886 (doi:10.3201/eid1412.080984) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kistler AL, et al. 2008. Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: identification of a candidate etiologic agent. Virol. J. 5, 88 (doi:10.1186/1743-422x-5-88) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Gregory CR, Latimer KS, Niagro FD, Ritchie BW, Campagnoil RP, Norton TM, McManamon R, Greenacre CB. 1994. A review of proventricular dilatation syndrome. J. Assoc. Avian Veterinarians 8, 69–75 (doi:10.2307/27671120) [Google Scholar]
- 39.Gancz AY, et al. 2009. Experimental induction of proventricular dilatation disease in cockatiels (Nymphicus hollandicus) inoculated with brain homogenates containing avian bornavirus 4. Virol. J. 6, 100 (doi:10.1186/1743-422x-6-100) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Gray P, et al. 2010. Use of avian bornavirus isolates to induce proventricular dilatation disease in conures. Emerg. Infect. Dis. 16, 473–479 (doi:10.3201/eid1603.091257) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.De Kloet SR, Dorrestein GM. 2009. Presence of avian bornavirus RNA and anti-avian bornavirus antibodies in apparently healthy macaws. Avian Dis. 53, 568–573 (doi:10.1637/8828-040209-reg.1) [DOI] [PubMed] [Google Scholar]
- 42.Horie M, Ueda K, Ueda A, Honda T, Tomonaga K. 2012. Detection of avian bornavirus 5 RNA in Eclectus roratus with feather picking disorder. Microbiol. Immunol. 56, 346–349 (doi:10.1111/j.1348-0421.2012.00436.x) [DOI] [PubMed] [Google Scholar]
- 43.Kistler AL, Smith JM, Greninger AL, Derisi JL, Ganem D. 2010. Analysis of naturally occurring avian bornavirus infection and transmission during an outbreak of proventricular dilatation disease among captive psittacine birds. J. Virol. 84, 2176–2179 (doi:10.1128/jvi.02191-09) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Weissenbock H, Sekulin K, Bakonyi T, Hogler S, Nowotny N. 2009. Novel avian bornavirus in a nonpsittacine species (canary; Serinus canaria) with enteric ganglioneuritis and encephalitis. J. Virol. 83, 11 367–11 371 (doi:10.1128/jvi.01343-09) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Payne S, Covaleda L, Jianhua G, Swafford S, Baroch J, Ferro PJ, Lupiani B, Heatley J, Tizard I. 2011. Detection and characterization of a distinct bornavirus lineage from healthy Canada geese (Branta canadensis). J. Virol. 85, 12 053–12 056 (doi:10.1128/jvi.05700-11) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Delnatte P, Berkvens C, Kummrow M, Smith DA, Campbell D, Crawshaw G, Ojkic D, DeLay J. 2011. New genotype of avian bornavirus in wild geese and trumpeter swans in Canada. Vet. Rec. 169, 108 (doi:10.1136/vr.d4620) [DOI] [PubMed] [Google Scholar]
- 47.Guo J, Covaleda L, Heatley JJ, Baroch JA, Tizard I, Payne SL. 2012. Widespread avian bornavirus infection in mute swans in the northeast United States. Vet. Med. 3, 49–52 (doi:10.2147/VMRR.S33353) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Weissenbock H, et al. 2009. Avian bornaviruses in psittacine birds from Europe and Australia with proventricular dilatation disease. Emerg. Infect. Dis. 15, 1453–1459 (doi:10.3201/eid1509.090353) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Rubbenstroth D, Rinder M, Kaspers B, Staeheli P. 2012. Efficient isolation of avian bornaviruses (ABV) from naturally infected psittacine birds and identification of a new ABV genotype from a salmon-crested cockatoo (Cacatua moluccensis). Vet. Microbiol. 161, 36–42 (doi:10.1016/j.vetmic.2012.07.004) [DOI] [PubMed] [Google Scholar]
- 50.Rubbenstroth D, et al. 2013. Avian bornaviruses are widely distributed in canary birds (Serinus canaria f. domestica). Vet. Microbiol. 165, 287–295 (doi:10.1016/j.vetmic.2013.03.024) [DOI] [PubMed] [Google Scholar]
- 51.Horie M, et al. 2010. Endogenous non-retroviral RNA virus elements in mammalian genomes. Nature 463, 84–87 (doi:10.1038/nature08695) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Fujino K, Horie M, Honda T, Nakamura S, Matsumoto Y, Francischetti IM, Tomonaga K. 2012. Evolutionarily conserved interaction between the phosphoproteins and X proteins of bornaviruses from different vertebrate species. PLoS ONE 7, e51161 (doi:10.1371/journal.pone.0051161) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Jern P, Coffin JM. 2008. Effects of retroviruses on host genome function. Annu. Rev. Genet. 42, 709–732 (doi:10.1146/annurev.genet.42.110807.091501) [DOI] [PubMed] [Google Scholar]
- 54.Lander ES, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (doi:10.1038/35057062) [DOI] [PubMed] [Google Scholar]
- 55.Waterston RH, et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520–562 (doi:10.1038/nature01262) [DOI] [PubMed] [Google Scholar]
- 56.Weiss RA. 2006. The discovery of endogenous retroviruses. Retrovirology 3, 67 (doi:10.1186/1742-4690-3-67) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Geuking MB, Weber J, Dewannieux M, Gorelik E, Heidmann T, Hengartner H, Zinkernagel RM, Hangartner L. 2009. Recombination of retrotransposon and exogenous RNA virus results in nonretroviral cDNA integration. Science 323, 393–396 (doi:10.1126/science.1167375) [DOI] [PubMed] [Google Scholar]
- 58.Klenerman P, Hengartner H, Zinkernagel RM. 1997. A non-retroviral RNA virus persists in DNA form. Nature 390, 298–301 (doi:10.1038/36876) [DOI] [PubMed] [Google Scholar]
- 59.Zhdanov VM. 1975. Integration of viral genomes. Nature 256, 471–473 (doi:10.1038/256471a0) [DOI] [PubMed] [Google Scholar]
- 60.Crochu S, Cook S, Attoui H, Charrel RN, De Chesse R, Belhouchet M, Lemasson JJ, de Micco P, de Lamballerie X. 2004. Sequences of flavivirus-related RNA viruses persist in DNA form integrated in the genome of Aedes spp. mosquitoes. J. Gen. Virol. 85, 1971–1980 (doi:10.1099/vir.0.79850-0) [DOI] [PubMed] [Google Scholar]
- 61.Maori E, Lavi S, Mozes-Koch R, Gantman Y, Peretz Y, Edelbaum O, Tanne E, Sela I. 2007. Isolation and characterization of Israeli acute paralysis virus, a dicistrovirus affecting honeybees in Israel: evidence for diversity due to intra- and inter-species recombination. J. Gen. Virol. 88, 3428–3438 (doi:10.1099/vir.0.83284-0) [DOI] [PubMed] [Google Scholar]
- 62.Tanne E, Sela I. 2005. Occurrence of a DNA sequence of a non-retro RNA virus in a host plant genome and its expression: evidence for recombination between viral and host RNAs. Virology 332, 614–622 (doi:10.1016/j.virol.2004.11.007) [DOI] [PubMed] [Google Scholar]
- 63.Belyi VA, Levine AJ, Skalka AM. 2010. Unexpected inheritance: multiple integrations of ancient bornavirus and ebolavirus/marburgvirus sequences in vertebrate genomes. PLoS Pathog. 6, e1001030 (doi:10.1371/journal.ppat.1001030) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Katzourakis A, Gifford RJ. 2010. Endogenous viral elements in animal genomes. PLoS Genet. 6, e1001191 (doi:10.1371/journal.pgen.1001191) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Kinnunen PM, et al. 2011. Intracerebral Borna disease virus infection of bank voles leading to peripheral spread and reverse transcription of viral RNA. PLoS ONE 6, e23622 (doi:10.1371/journal.pone.0023622) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Rauer M, Gotz J, Schuppli D, Staeheli P, Hausmann J. 2004. Transgenic mice expressing the nucleoprotein of Borna disease virus in either neurons or astrocytes: decreased susceptibility to homotypic infection and disease. J. Virol. 78, 3621–3632 (doi:10.1128/JVI.78.7.3621-3632.2004) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Whelan SP, Barr JN, Wertz GW. 2004. Transcription and replication of nonsegmented negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 283, 61–119 (doi:10.1007/978-3-662-06099-5_3) [DOI] [PubMed] [Google Scholar]
- 68.Zhang Z, Carriero N, Gerstein M. 2004. Comparative analysis of processed pseudogenes in the mouse and human genomes. Trends Genet. 20, 62–67 (doi:10.1016/j.tig.2003.12.005) [DOI] [PubMed] [Google Scholar]
- 69.O'Leary MA, et al. 2013. The placental mammal ancestor and the post-K-Pg radiation of placentals. Science 339, 662–667 (doi:10.1126/science.1229237) [DOI] [PubMed] [Google Scholar]
- 70.Singer MF. 1995. Unusual reverse transcriptases. J. Biol. Chem. 270, 24 623–24 626 [DOI] [PubMed] [Google Scholar]
- 71.Babushok DV, Kazazian HH., Jr 2007. Progress in understanding the biology of the human mutagen LINE-1. Hum. Mutat. 28, 527–539 (doi:10.1002/humu.20486) [DOI] [PubMed] [Google Scholar]
- 72.Esnault C, Maestre J, Heidmann T. 2000. Human LINE retrotransposons generate processed pseudogenes. Nat. Genet. 24, 363–367 (doi:10.1038/74184) [DOI] [PubMed] [Google Scholar]
- 73.Maestre J, Tchenio T, Dhellin O, Heidmann T. 1995. mRNA retroposition in human cells: processed pseudogene formation. EMBO J. 14, 6333–6338 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Gilbert N, Lutz-Prigge S, Moran JV. 2002. Genomic deletions created upon LINE-1 retrotransposition. Cell 110, 315–325 (doi:10.1016/S0092-8674(02)00828-0) [DOI] [PubMed] [Google Scholar]
- 75.Morrish TA, Gilbert N, Myers JS, Vincent BJ, Stamato TD, Taccioli GE, Batzer MA, Moran JV. 2002. DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat. Genet. 31, 159–165 (doi:10.1038/ng898) [DOI] [PubMed] [Google Scholar]
- 76.Symer DE, Connelly C, Szak ST, Caputo EM, Cost GJ, Parmigiani G, Boeke JD. 2002. Human l1 retrotransposition is associated with genetic instability in vivo. Cell 110, 327–338 (doi:10.1016/S0092-8674(02)00839-5) [DOI] [PubMed] [Google Scholar]
- 77.Ohshima K, Hattori M, Yada T, Gojobori T, Sakaki Y, Okada N. 2003. Whole-genome screening indicates a possible burst of formation of processed pseudogenes and Alu repeats by particular L1 subfamilies in ancestral primates. Genome Biol. 4, R74 (doi:10.1186/gb-2003-4-11-r74) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Aswad A, Katzourakis A. 2012. Paleovirology and virally derived immunity. Trends Ecol. Evol. 27, 627–636 (doi:10.1016/j.tree.2012.07.007) [DOI] [PubMed] [Google Scholar]
- 79.Blaise S, de Parseval N, Benit L, Heidmann T. 2003. Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. Proc. Natl Acad. Sci. USA 100, 13 013–13 018 (doi:10.1073/pnas.2132646100) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Dupressoir A, Marceau G, Vernochet C, Benit L, Kanellopoulos C, Sapin V, Heidmann T. 2005. Syncytin-A and syncytin-B, two fusogenic placenta-specific murine envelope genes of retroviral origin conserved in Muridae. Proc. Natl Acad. Sci. USA 102, 725–730 (doi:10.1073/pnas.0406509102) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Dupressoir A, Vernochet C, Bawa O, Harper F, Pierron G, Opolon P, Heidmann T. 2009. Syncytin-A knockout mice demonstrate the critical role in placentation of a fusogenic, endogenous retrovirus-derived, envelope gene. Proc. Natl Acad. Sci. USA 106, 12 127–12 132 (doi:10.1073/pnas.0902925106) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Mi S, et al. 2000. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403, 785–789 (doi:10.1038/35001608) [DOI] [PubMed] [Google Scholar]
- 83.Ewing RM, et al. 2007. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol. Syst. Biol. 3, 89 (doi:10.1038/msb4100134) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Kobayashi Y, Horie M, Tomonaga K, Suzuki Y. 2011. No evidence for natural selection on endogenous borna-like nucleoprotein elements after the divergence of Old World and New World monkeys. PLoS ONE 6, e24403 (doi:10.1371/journal.pone.0024403) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Goic B, et al. 2013. RNA-mediated interference and reverse transcription control the persistence of RNA viruses in the insect model Drosophila. Nat. Immunol. 14, 396–403 (doi:10.1038/ni.2542) [DOI] [PubMed] [Google Scholar]
- 86.Planz O, Stitz L. 1999. Borna disease virus nucleoprotein (p40) is a major target for CD8+-T-cell-mediated immune response. J. Virol. 73, 1715–1718 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Stitz L, Bilzer T, Planz O. 2002. The immunopathogenesis of Borna disease virus infection. Front. Biosci. 7, d541–d545 (doi:10.2741/stitz) [DOI] [PubMed] [Google Scholar]
- 88.Schneider U, Naegele M, Staeheli P, Schwemmle M. 2003. Active Borna disease virus polymerase complex requires a distinct nucleoprotein-to-phosphoprotein ratio but no viral X protein. J. Virol. 77, 11 781–11 789 (doi:10.1128/JVI.77.21.11781-11789.2003) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Murcia PR, Arnaud F, Palmarini M. 2007. The transdominant endogenous retrovirus enJS56A1 associates with and blocks intracellular trafficking of Jaagsiekte sheep retrovirus gag. J. Virol. 81, 1762–1772 (doi:10.1128/JVI.01859-06) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Giboulet O, Chevret P, Ramousse R, Catzeflis F. 1997. DNA–DNA hybridization evidence for the recent origin of marmots and ground squirrels (Rodentia: Sciuridae). J. Mamm. Evol. 4, 271–284 (doi:10.1023/A:1027326631342) [Google Scholar]
- 91.Obolenskaya EV, Lee MY, Dokuchaev NE, Oshida T, Lee MS, Lee H, Lissovsky AA. 2009. Diversity of Palaearctic chipmunks (Tamias, Sciuridae). Mammalia 73, 281–298 (doi:10.1515/MAMM.2009.047) [Google Scholar]
- 92.Platt RN, II, Ray DA. 2012. A non-LTR retroelement extinction in Spermophilus tridecemlineatus. 500, 47–53 (doi:10.1016/j.gene.2012.03.051) [DOI] [PubMed] [Google Scholar]
- 93.Arnaud F, et al. 2007. A paradigm for virus–host coevolution: sequential counter-adaptations between endogenous and exogenous retroviruses. PLoS Pathog. 3, e170 (doi:10.1371/journal.ppat.0030170) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Feschotte C. 2010. Virology: bornavirus enters the genome. Nature 463, 39–40 (doi:10.1038/463039a) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Horie M, Tomonaga K. 2011. Non-retroviral fossils in vertebrate genomes. Viruses 3, 1836–1848 (doi:10.3390/v3101836) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Brnic D, Stevanovic V, Cochet M, Agier C, Richardson J, Montero-Menei CN, Milhavet O, Eloit M, Coulpier M. 2012. Borna disease virus infects human neural progenitor cells and impairs neurogenesis. J. Virol. 86, 2512–2522 (doi:10.1128/jvi.05663-11) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Coufal NG, et al. 2009. L1 retrotransposition in human neural progenitor cells. Nature 460, 1127–1131 (doi:10.1038/nature08248) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Daito T, Fujino K, Honda T, Matsumoto Y, Watanabe Y, Tomonaga K. 2011. A novel Borna disease virus vector system that stably expresses foreign proteins from an intercistronic noncoding region. J. Virol. 85, 12 170–12 178 (doi:10.1128/jvi.05554-11) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Jordan A, Bisgrove D, Verdin E. 2003. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868–1877 (doi:10.1093/emboj/cdg188) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Coffin JM, Hughes SH, Varmus HE. (eds) 1997. Retroviruses. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; Experimental Applications. Available at http://www.ncbi.nlm.nih.gov/books/NBK19399/ [PubMed] [Google Scholar]